1988
DOI: 10.1007/bf00172963
|View full text |Cite
|
Sign up to set email alerts
|

The NK-3 tachykinin agonist senktide elicits yawning and chewing mouth movements following subcutaneous administration in the rat. Evidence for cholinergic mediation

Abstract: The selective NK-3 tachykinin receptor agonist senktide elicited yawning, chewing mouth movements and sexual arousal following subcutaneous administration (0.1-1.0 mg/kg) in the rat. These responses were not significantly affected by the dopamine antagonist haloperidol (0.03 mg/kg) or by 6-hydroxydopamine lesions of the nigrostriatal projection. In contrast, the behaviours were markedly attenuated by the peripheral and central muscarinic antagonist scopolamine (1 mg/kg), but not by the peripheral muscarinic an… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

1990
1990
2007
2007

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 17 publications
(2 citation statements)
references
References 34 publications
0
2
0
Order By: Relevance
“…The doses of senktide used in the present study were chosen on the basis of evidence from other studies (Stoessl et al ., 1988a,b) showing behavioural activity of the compound in the range of 0.1–1.0 mg/kg after s.c. administration. Senktide is a ligand with both high selectivity and equally high affinity for NK 3 ‐Rs of different species (Laufer et al ., 1986).…”
Section: Discussionmentioning
confidence: 99%
“…The doses of senktide used in the present study were chosen on the basis of evidence from other studies (Stoessl et al ., 1988a,b) showing behavioural activity of the compound in the range of 0.1–1.0 mg/kg after s.c. administration. Senktide is a ligand with both high selectivity and equally high affinity for NK 3 ‐Rs of different species (Laufer et al ., 1986).…”
Section: Discussionmentioning
confidence: 99%
“…(Stoessl et al, 1988a;Picard et al, 1994). However, intracisternal or subcutaneous administration of senktide in the rat has been also reported to produce a syndrome mediated by endogenous 5-HT including forepaw treading and hindlimb splaying (Wormser et al, 1986;Stoessl et al, 1987) and acetylcholinemediated behaviours, yawning, chewing mouth movements and sexual arousal (Stoessl et al, 1988b (Dam & Quirion, 1986;Stoessl et al, 1991). Surprisingly, in our experiments, only the NKI receptor agonists, when administered centrally to conscious freely moving guinea-pigs, lead to enhanced locomotion, the NK3 receptor agonist senktide being inactive.…”
Section: Discussionmentioning
confidence: 99%